 |
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
PRISMEDICAL News
FOR IMMEDIATE RELEASE
PRISMEDICAL AWARDED $1M CONTRACT BY OFFICE OF NAVAL RESEARCH FOR PRODUCTION OF THERAPEUTIC SOLUTIONS IN FIELD SETTINGS
Project Aimed to Provide Immediate Trauma Care with Lightweight Portable Devices That Are Easy to Transport
Napa, CA, July 25, 2003 PRISMEDICAL announced today the award of a $1 million research contract from the Office of Naval Research to produce IV solutions in field settings. Lightweight portable devices that produce sterile therapeutic solutions from available contaminated “field” water sources in remote locations can increase the success rate of treatment during the “golden hour” while reducing logistics and transportation costs. This contract is an extension of the research conducted under a 2002 contract awarded to PRISMEDICAL for investigating the feasibility of developing a lightweight portable device to produce potable (drinking) water from available contaminated “field” water.
“We are pleased that the Office of Naval Research has awarded us a second contract to expand our capabilities from decontaminating field water to using field water to produce sterile therapeutic solutions,” said Mark Sizelove, president and CEO. “The ability to treat pre-hospital trauma quickly with a lightweight portable device, whether it is in a military field setting or civilian settings such as emergency response or humanitarian disaster relief, can greatly increase patient survival rate.”
Providing Critical Care During the “Golden Hour”
According to the United States Department of Defense (DoD), 80% of all battlefield deaths are caused by the unavailability of life sustaining IV solutions at the place and time of trauma, commonly referred to as the “golden hour” or first 60 minutes after injury. It is essential that fluids are replaced quickly to avoid acute blood loss and subsequent organ failure and that these fluids are delivered with the required and appropriate drug therapy.
Field and pre-hospital settings also have the constraint of portability and require that these IV fluids are easy to transport and use. Current solutions limit medical mobility as the primary component, water, accounts for over 90% of the weight and volume needed for therapy.
As part of this contract, PRISMEDICAL is researching and developing products that combine the FDA approved MainStream® Water Purification Device with approved drug formulations. MainStream is a hand-held disposable device requiring no power source that can produce three liters of Sterile Purified Water, USP, within 30 minutes from any available water source. As the size of a soda can and weighing 1.1 lbs, this compact and lightweight device is one sixth the bulk and weight of shipping water, dramatically reducing logistic and transportation costs.
“Our goal is to build upon the past success of producing sterile purified water in a field setting to delivering a whole line of drug delivery systems that can be activated on demand at the point-of-use,” said Sizelove.
PRISMEDICAL AWARDED $1M CONTRACT BY OFFICE OF NAVAL RESEARCH FOR PRODUCTION OF THERAPEUTIC SOLUTIONS IN FIELD SETTINGS
Project Aimed to Provide Immediate Trauma Care with Lightweight Portable Devices That Are Easy to Transport
Napa, CA, July 25, 2003 PRISMEDICAL announced today the award of a $1 million research contract from the Office of Naval Research to produce IV solutions in field settings. Lightweight portable devices that produce sterile therapeutic solutions from available contaminated “field” water sources in remote locations can increase the success rate of treatment during the “golden hour” while reducing logistics and transportation costs. This contract is an extension of the research conducted under a 2002 contract awarded to PRISMEDICAL for investigating the feasibility of developing a lightweight portable device to produce potable (drinking) water from available contaminated “field” water.
“We are pleased that the Office of Naval Research has awarded us a second contract to expand our capabilities from decontaminating field water to using field water to produce sterile therapeutic solutions,” said Mark Sizelove, president and CEO. “The ability to treat pre-hospital trauma quickly with a lightweight portable device, whether it is in a military field setting or civilian settings such as emergency response or humanitarian disaster relief, can greatly increase patient survival rate.”
Providing Critical Care During the “Golden Hour”
According to the United States Department of Defense (DoD), 80% of all battlefield deaths are caused by the unavailability of life sustaining IV solutions at the place and time of trauma, commonly referred to as the “golden hour” or first 60 minutes after injury. It is essential that fluids are replaced quickly to avoid acute blood loss and subsequent organ failure and that these fluids are delivered with the required and appropriate drug therapy.
Field and pre-hospital settings also have the constraint of portability and require that these IV fluids are easy to transport and use. Current solutions limit medical mobility as the primary component, water, accounts for over 90% of the weight and volume needed for therapy.
As part of this contract, PRISMEDICAL is researching and developing products that combine the FDA approved MainStream® Water Purification Device with approved drug formulations. MainStream is a hand-held disposable device requiring no power source that can produce three liters of Sterile Purified Water, USP, within 30 minutes from any available water source. As the size of a soda can and weighing 1.1 lbs, this compact and lightweight device is one sixth the bulk and weight of shipping water, dramatically reducing logistic and transportation costs.
“Our goal is to build upon the past success of producing sterile purified water in a field setting to delivering a whole line of drug delivery systems that can be activated on demand at the point-of-use,” said Sizelove.